Cases and resources in vascular techniques
This section provides a selection of cases and resources provided by experts in vascular techniques.
A 75-mm saccular juxtarenal aneurysm had rapidly expanded in a patient with weight loss and an inflammatory response. What treatment strategy would you choose in this challenging setting?
In this episode, Dr Alexandros Mallios speaks with Dr William Jennings about the principles guiding surgical arteriovenous fistula creation. From vessel assessment and ultrasound mapping to proximal radial artery fistulas and evolving surgical strategies, the discussion explores the clinical reasoning behind choosing the right access for each patient.
Dr Ruiz Chiriboga and Dr Leal Lorenzo explore what CREST-2 could mean for the management of asymptomatic carotid disease, while discussing new-generation stents, flow reversal and the importance of measuring individual outcomes.
How much has the haemodialysis catheter really evolved? Prof. Maurizio Gallieni and Dr Edoardo Pasqui discuss persistent challenges in vascular access, from infection and thrombosis to central venous injury, and explore where innovation is still needed to improve long-term patient outcomes.
Dr Tara Mastracci discusses the evolution of complex aortic surgery with Dr Marta Lobato, exploring clinical decision-making, aortic dissection, emerging technologies and the impact of social deprivation on patient outcomes. She also reflects on her journey as a woman in vascular surgery, the importance of leadership and mentorship, and what the next generation of aortic surgeons can expect from the field.
The TRACK trial found that low-dose rivaroxaban did not reduce cardiovascular events in advanced CKD, but significantly increased major bleeding.
Explore the role of atherectomy in complex femoropopliteal lesions, from patient selection and stent avoidance to its combination with DCB.
How has embolisation evolved beyond emergency bleeding control? Dr Ruiz Chiriboga and Dr Lelij explore the expanding indications for embolisation, key decision-making factors, type II endoleak management, and the imaging advances that are transforming everyday vascular practice.
Why do many PAD patients still present too late? Dr Ralf Langhoff shares his perspective on the challenges facing PAD care in Europe and the actions needed to improve awareness, evidence generation and patient outcomes.
Paclitaxel-coated technologies have significantly improved outcomes after femoropopliteal interventions, but concerns over long-term mortality have remained. New evidence from the SWEDEPAD 2 trial has prompted a focused update of the 2024 ESVS Guidelines.
